Status:
COMPLETED
Dexmedetomidine Combined With Hydromorphone in Tonsillectomy and Adenoidectomy
Lead Sponsor:
Eye & ENT Hospital of Fudan University
Conditions:
Agitated; State, Acute Reaction to Stress
Eligibility:
All Genders
3-10 years
Phase:
PHASE4
Brief Summary
Tonsillectomy and adenoidectomy is one of the most common pediatric surgeries, and agitation and severe postoperative pain have been considered a very common complications. Dexmedetomidine mainly inhi...
Detailed Description
The computer generates random numbers to allocate patients into different group. Trained research staff who are not involved in the study collect the data. The observer who only stayed in PACU was bli...
Eligibility Criteria
Inclusion
- experienced tonsillectomy and adenoidectomy
- ASA physical status I-II
- weight 12-30 kg
Exclusion
- respiratory disease
- circulatory or nervous system disease
- hepatic dysfunction
- known adverse reactions to hydromophine and dexmedetomidine
Key Trial Info
Start Date :
January 4 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2019
Estimated Enrollment :
130 Patients enrolled
Trial Details
Trial ID
NCT03760809
Start Date
January 4 2019
End Date
April 1 2019
Last Update
June 22 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Anesthesiology Department of Affiliated Eye and ENT Hospital, Fudan University
Shanghai, Shanghai Municipality, China, 200031